Literature DB >> 7738153

Quantitation of human cytomegalovirus glycoprotein H gene in cells using competitive PCR and a rapid fluorescence-based detection system.

G Boivin1, C A Olson, M R Quirk, S M St-Cyr, M C Jordan.   

Abstract

A technique is described for quantitation of the human cytomegalovirus (HCMV) glycoprotein H (gH) gene in cells using a quantitative-competitive polymerase chain reaction (QC-PCR). Two recombinant DNA molecules, differing in size due to a 92-bp deletion within the HCMV gH sequence, were used in co-amplification studies to construct a standard curve from which the copy number of the gH gene present in clinical samples could be interpolated. The use of primers labeled with a fluorescent dye allowed direct detection of the amplified products by measuring the amount of fluorescence emitted by each specific PCR fragment with an automated DNA sequencer coupled to a software program. This system was validated subsequently using bronchoalveolar lavage cells obtained from immunocompromised patients and found to be highly sensitive and reproducible over a range of 5-50,000 HCMV gH copies. This rapid procedure could easily be applied to study the pathogenesis of HCMV infection, identify the patients at high risk of developing HCMV disease, and monitor the effects of antiviral therapy at the molecular level.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7738153     DOI: 10.1016/0166-0934(94)00128-4

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  11 in total

1.  Comparison of a duplex quantitative real-time PCR assay and the COBAS Amplicor CMV Monitor test for detection of cytomegalovirus.

Authors:  Björn Herrmann; Viviana Cavaglia Larsson; Carl-Johan Rubin; Fredrik Sund; Britt-Marie Eriksson; Johan Arvidson; Zhibing Yun; Kåre Bondeson; Jonas Blomberg
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

2.  The scope of quantitative polymerase chain reaction assays in clinical molecular pathology.

Authors:  R D Malcomson; C T McCullough; D J Bruce; D J Harrison
Journal:  Clin Mol Pathol       Date:  1995-08

3.  Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the SHARP Signal Detection System.

Authors:  G Boivin; J Handfield; G Murray; E Toma; R Lalonde; J G Lazar; M G Bergeron
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

4.  Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCR.

Authors:  T C Roberts; R S Buller; M Gaudreault-Keener; K E Sternhell; K Garlock; G G Singer; D C Brennan; G A Storch
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

5.  Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.

Authors:  G Gerna; F Baldanti; D Lilleri; M Parea; E Alessandrino; A Pagani; F Locatelli; J Middeldorp; M G Revello
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Rising levels of human cytomegalovirus (HCMV) antigenemia during initial antiviral treatment of solid-organ transplant recipients with primary HCMV infection.

Authors:  G Gerna; M Zavattoni; E Percivalle; P Grossi; M Torsellini; M G Revello
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

7.  Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.

Authors:  G Gerna; F Baldanti; J M Middeldorp; M Furione; M Zavattoni; D Lilleri; M G Revello
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

8.  Early effects of ganciclovir therapy on the quantity of cytomegalovirus DNA in leukocytes of immunocompromised patients.

Authors:  G Boivin; M R Quirk; B A Kringstad; M Germain; M C Jordan
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

9.  Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS.

Authors:  H H Balfour; C V Fletcher; A Erice; W K Henry; E P Acosta; S A Smith; M A Holm; G Boivin; D H Shepp; C S Crumpacker; C A Eaton; S S Martin-Munley
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

Review 10.  Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.

Authors:  Maria Grazia Revello; Giuseppe Gerna
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.